NMR data are shown in Table 1 and in the Supplementary materials (Supplementary Figures 2S, 3S , 4aS, 4bS). NMR spectra were recorded at 298 K on Varian INOVA 500 MHz spectrometer (Varian, Palo Alto, CA, USA) operated at 499.8 MHz for 1 H. The 2D experiments were run by using the standard Varian software, except the HMBC experiment. 8, 9 The 1 H NMR spectrum consists of seven signals: an ABM system in the aromatic part at 6.85, 6.70 and 6.79 p.p.m. (3H); an ABX aliphatic system at 2.80, 3.06 and 4.38 p.p.m. (3H); and a singlet from the CH 3 group at 1.93 p.p.m. (3H). Dynamic OH, COOH and NH protons are in fast exchange with bulk water and are not observed in the 1 H NMR spectrum. The assignment of protons was accomplished following the general rule of chemical-shift dispersion, using the proton-proton coupling pattern and the COSY spectrum.
Carbon resonances were obtained from the 1 H-{ 13 C} HSQC (Supplementary Figures 4aS, 4bS) (six signals of proton-bearing carbon atoms) and 1 H { 13 C} HMBC (five signals of the quaternary carbon atoms) spectra. The 1 H { 13 C} HMBC spectrum was used also as a final tool to make assignment of carbon resonance and to confirm the structure of JS-2.
IR absorption at 3366 and 1724-1608 cm À1 suggested the presence of hydroxyl and carbonyl groups in the structure (Supplementary Figure 5S) . The UV spectrum showed a typical pattern for an aromatic compound. Strong absorption at 280 nm confirmed a phenolic moiety (Supplementary Figure 6S) . According to the interpretation of these data, compound JS-2 presents the structure of N-acetyl-3,4-dihydroxy-L-phenylalanine.
Unequivocal confirmation of the JS-2 structure has been obtained by its comparison with a synthetic sample prepared by acetylation of L-Dopa with excess of acetic anhydride in hot water. The analytical sample was obtained by preparative HPLC (RPC18, 5% acetonitrile in 0.1% aq. AcOH). The spectral data of the obtained product fully agreed with the above analysis.
Under the procedures described previously, [10] [11] [12] the inhibitory effect of DD-carboxypeptidases activity was measured. Thioester C 6 H 5 -CO-NH-(D)CH(CH 3 )-CO-S-CH 2 -COOH was used as a substrate 10, 12 (Supplementary Bioassay). JS-2 and structurally related compounds, 3,4-dihydroxy-L-phenylalanine (Sigma, St Louis, MO, USA), 3,4-dihydroxy-D-phenylalanine (Sigma) and N-acetyl-3,4-dihydroxy-D-phenylalanine (synthesized analogously as L-form) were examined. The IC 50 values of these compounds for DD-peptidases 64-575 II and R39 are presented in Table 2 .
Results showed that IC 50 values ranged from 3.96 to 17.79 mM. The IC 50 values of JS-2 for DD-peptidase 64-575 II and for DD-peptidase R39 were compared with the IC 50 values of L-Dopa, D-Dopa and Nacetyl-D-Dopa for these enzymes. The IC 50 values of JS-2 for DDpeptidases 64-575 II and R39 were the lowest. In each case, L-isomer of the compound inhibited both DD-peptidases in lower concentration than the D-isomer. Furthermore, the inhibitory activity of evaluated compounds was weaker for DD-peptidase 64-575 II than for DDpeptidase R39.
The IC 50 values of b-lactam antibiotics for DD-peptidase 64-575 II and R39 were compared with the IC 50 values of JS-2 for both enzymes. 5, 13 IC 50 values of many b-lactam antibiotics (ranging from 1.6 mM to 0.015 mM) for DD-peptidase 64-575 II, as well as for DDpeptidase R39 (ranging from 5 to 0.03 mM) were lower than the IC 50 value of the investigated compounds for these enzymes. JS-2 exhibited weak inhibitory effects on the DD-peptidases 64-575 II and R39. However, so far, no protoalkaloid inhibitors of DD-peptidases have been described.
To examine the specificity spectrum of the JS-2 compound, inhibition assays were performed for a range of common proteolytic enzymes: pancreatic elastase (type IV) from porcine pancreas, carboxypeptidase A from bovine pancreas, trypsin from porcine pancreas, and papain from Papaya latex, according to the procedures described in our previous paper, 3 and leucine aminopeptidase (type IV-S) from porcine kidney microsomes as reported by Cahan et al. 14 It was determined that at a concentration of 1.4 mM, the JS-2 compound causes 50% inhibition of carboxypeptidase A, whereas the rest of the enzymes remained active at higher concentration, 1.84 mM.
Antibacterial activity of JS-2 was tested by liquid microdilution method (Spectrostar Omega, BMG Labtech, Offenburg, Germany), under standard conditions according to the CLSI references. 15 A panel of Gram-positive and Gram-negative bacterial strains was used (Supplementary Bioassay). The JS-2 compound showed weak antibacterial activity against B. bronchiseptica, S. aureus (MRSA and VRSA) and S. epidermidis (Table 2) . Moreover, JS-2 showed a 4-h delay of growth of S. aureus (MSSA) at 256 mg ml À1 , a 2.5-h delay of bacterial growth at concentration 128 mg ml À1 , and a 2-h delay of bacterial growth at 64 mg ml À1 , although the general MIC value for bioactive metabolite J Solecka et al this bacteria was higher than 256 mg ml À1 (Supplementary Figure 7S) . Additionally, for comparison, the antimicrobial activity of compounds: 3,4-dihydroxy-L-phenylalanine, 3,4-dihydroxy-D-phenylalanine and N-acetyl-3,4-dihydroxy-D-phenylalanine were examined. These compounds showed a slightly higher activity than JS-2 (Table 2) . Moreover, other activities of JS-2 were also examined, including genotoxicity and hemolytic properties. For assessment of genotoxicity, two genetically modified Bacillus subtilis strains, M45 rec À and H17 rec + , obtained from Dr Yoshito Sadaie (Department of Induced Mutation, National Institute of Genetics, Shizuoka, Japan) were examined by the disc-diffusion method according to Kada's procedure. 3, 16 The JS-2 compound did not inhibit the growth of the tested B. subtilis strains; hence, it was determined as nongenotoxic.
The hemolysis test was carried out according to a method described in literature. 3 No hemolytic activity of JS-2 was observed on human erythrocytes.
In conclusion, N-acetyl-3,4-dihydroxy-L-phenylalanine (JS-2) had been identified earlier as a Streptomyces akiyoshiensis metabolite 17 and obtained by semisynthesis using microorganisms; for example, Pseudomonas striafaciens and Vibrio tyrosinaticus. 18, 19 Only its antitumour properties were studied so far. 17,20 DD-peptidase inhibitory activity and antimicrobial properties of JS-2 have not been previously defined. JS-2 compound belongs to a group of protoalkaloids, b-phenylethylamines and -amides isolated usually as plant metabolites. 21 Results of this study demonstrate that b-phenylethylamides, like JS-2, may show antimicrobial activities and inhibitory properties on some closely related proteinases (for example DD-peptidases).
Natural compounds themselves are highly important, as they constitute also the basis for developing synthetic drugs. In the last 10 years among the launched antibiotics, there are more natural product-derivative new antibiotic templates compared with those synthetically derived. 1 Protoalkaloid JS-2 shows weak antibacterial activity; however, due to the lack of hemolytic properties and genotoxicity, it can be considered as a candidate for chemical modifications that can increase its antibacterial activity.
